Document Detail


Phasic hemodynamics and reverse blood flows in the aortic isthmus and pulmonary arteries of preterm lambs with pulmonary vascular dysfunction.
MedLine Citation:
PMID:  18820030     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Time-domain representations of the fetal aortopulmonary circulation were carried out in lamb fetuses to study hemodynamic consequences of congenital diaphragmatic hernia (CDH) and the effects of endothelin-receptor antagonist tezosentan (3 mg/45 min). From the isthmic aortic and left pulmonary artery (PA) flows (Q) and isthmic aortic, PA, and left auricle pressures (P) on day 135 in 10 controls and 7 CDH fetuses (28 ewes), discrete-triggered P and Q waveforms were modelized as Pt and Qt functions to obtain basic hemodynamic profiles, pulsatile waves [P, Q, and entry impedance (Ze)], and P and Q hysteresis loops. In the controls, blood propelling energy was accounted for by biventricular ejection flow waves (kinetic energy) with low Ze and by flow-driven pressure waves (potential energy) with low Ze. Weak fetal pulmonary perfusion was ensured by reflux (reverse flows) from PA branches to the ductus anteriosus and aortic isthmus as reverse flows. Endothelin-receptor antagonist blockade using tezosentan slightly increased the forward flow but largely increased diastolic backward flow with a diminished left auricle pre- and postloading. In CHD fetuses, the static component overrode phasic flows that were detrimental to reverse flows and the direction of the diastolic isthmic flow changed to forward during the diastole period. Decreased cardiac output, flattened pressure waves, and increased forward Ze promoted backward flow to the detriment of forward flow (especially during diastole). Additionally, the intrapulmonary arteriovenous shunting was ineffective. The slowing of cardiac output, the dampening of energetic pressure waves and pulsatility, and the heightening of phasic impedances contributed to the lowering of aortopulmonary blood flows. We speculate that reverse pulmonary flow is a physiological requirement to protect the fetal pulmonary circulation from the prominent right ventricular stream and to enhance blood flow to the fetal heart and brain.
Authors:
Pierre-Henri Rolland; Pascal de Lagausie; Euletheris Stathopoulos; Olivier Leprètre; Gilles Viudes; Guillaume Gorincour; Géraldine Hery; Catherine de Magnée; Olivier Paut; Jean-Michel Guys
Publication Detail:
Type:  Journal Article     Date:  2008-09-26
Journal Detail:
Title:  American journal of physiology. Heart and circulatory physiology     Volume:  295     ISSN:  0363-6135     ISO Abbreviation:  Am. J. Physiol. Heart Circ. Physiol.     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2008-12-09     Completed Date:  2009-01-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100901228     Medline TA:  Am J Physiol Heart Circ Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  H2231-41     Citation Subset:  IM    
Affiliation:
Physiopathology and Vascular Therapeutics, School of Medicine, University of the Mediterranean Sea, 27 Blvd. Jean-Moulin, and Department of Pediatric Surgery, LaTimone-Hospital, Marseilles, France. pierre-henri.rolland@univmed.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Aorta / drug effects,  embryology,  physiopathology*
Blood Pressure
Cardiac Output
Fetus / blood supply
Gestational Age
Hemodynamics* / drug effects
Hernia, Diaphragmatic / congenital,  pathology,  physiopathology*
Lung / blood supply*,  embryology,  ultrastructure
Microscopy, Electron, Scanning
Pulmonary Artery / drug effects,  embryology,  physiopathology*,  ultrastructure
Pulmonary Circulation* / drug effects
Pulsatile Flow
Pyridines / pharmacology
Receptors, Endothelin / antagonists & inhibitors
Regional Blood Flow
Sheep
Tetrazoles / pharmacology
Time Factors
Vasoconstriction
Vasodilator Agents / pharmacology
Chemical
Reg. No./Substance:
0/Pyridines; 0/Receptors, Endothelin; 0/Tetrazoles; 0/Vasodilator Agents; 0/tezosentan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure.
Next Document:  Nitrite consumption in ischemic rat heart catalyzed by distinct blood-borne and tissue factors.